US: Potential Insulin Market
The increasing diabetes prevalence in US has contributed towards the development of effective and reasonable insulin delivery devices across the country. Certain other factors including increasing ageing population, rising obesity and the changing lifestyle habits of the US population also lead to the growth in this market. However, the market has showcased significant development with respect to capabilities of leading players such as Novo Nordisk, Sanofi, Eli Lily. These players have been aggressively involved in marketing and R&D efforts.
View full press release